{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:18:37Z","timestamp":1790803117078,"version":"4.1.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.autrev.2016.09.023","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T17:38:52Z","timestamp":1474652332000},"page":"34-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Role of galectin-3 in autoimmune and non-autoimmune nephropathies"],"prefix":"10.1016","volume":"16","author":[{"given":"Francesca","family":"Saccon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariele","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ghirardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.09.023_bb0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/1535370215593826","article-title":"Galectin-3 in autoimmunity and autoimmune diseases","volume":"240","author":"de Oliveira","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.autrev.2016.09.023_bb0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2009.05131.x","article-title":"Galectins: regulators of acute and chronic inflammation","volume":"1183","author":"Liu","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2016.09.023_bb0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nri2536","article-title":"Turning \u2018sweet\u2019 on immunity: galectin-glycan interactions in immune tolerance and inflammation","volume":"9","author":"Rabinovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4049\/jimmunol.176.2.778","article-title":"Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death","volume":"176","author":"Stillman","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fimmu.2012.00199","article-title":"Galectins as self\/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox","volume":"3","author":"Vasta","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0030","doi-asserted-by":"crossref","first-page":"20807","DOI":"10.1016\/S0021-9258(17)31891-4","article-title":"Galectins. Structure and function of a large family of animal lectins","volume":"269","author":"An Barondes","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.09.023_bb0035","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1074\/jbc.M808925200","article-title":"Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation","volume":"284","author":"ZK","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2016.09.023_bb0040","first-page":"5272","article-title":"Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family","volume":"57","author":"Akahani","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2016.09.023_bb0045","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1158\/0008-5472.CAN-08-1245","article-title":"Tumor-associated galectin-3 modulates the function of tumor-reactive T cells","volume":"68","author":"Peng","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2016.09.023_bb0050","series-title":"Essentials of Glycobiology","article-title":"S-type lectins (galectins)","author":"Cummings","year":"1999"},{"key":"10.1016\/j.autrev.2016.09.023_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00798.x","article-title":"Galectin-3 regulates T-cell functions","volume":"230","author":"Hsu","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0060","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1038\/jid.2012.211","article-title":"Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migration","volume":"132","author":"Liu","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-014-0099-8","article-title":"Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt\/\u03b2-catenin signaling pathway","volume":"8","author":"Hu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/glycob\/cwj035","article-title":"Exploring the role of galectin 3 in kidney function: a genetic approach","volume":"16","author":"Bichara","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2016.09.023_bb0075","first-page":"1417","article-title":"Immunohistochemical localization of galectins-1 and -3 and monitoring of tissue galectin-binding sites during tubular regeneration after renal ischemia reperfusion in the rat","volume":"25","author":"Vansthertem","year":"2010","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<481::AID-PATH263>3.0.CO;2-2","article-title":"Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies","volume":"187","author":"Sasaki","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0085","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ndt\/gfg603","article-title":"Galectin-3-positive cell infiltration in human diabetic nephropathy","volume":"19","author":"Kikuchi","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2016.09.023_bb0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10157-014-1009-7","article-title":"Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever","volume":"19","author":"Yilmaz","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0095","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2353\/ajpath.2006.060245","article-title":"Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease","volume":"169","author":"Chiu","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0100","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2015101100","article-title":"Mucin-1 increases renal TRPV5 activity in vitro, and urinary level associates with calcium nephrolithiasis in patients","author":"Nie","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0105","doi-asserted-by":"crossref","first-page":"F611","DOI":"10.1152\/ajprenal.00435.2004","article-title":"Development of age-dependent glomerular lesions in galectin-3\/AGE-receptor-3 knockout mice","volume":"289","author":"Iacobini","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0110","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.09.023_bb0115","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.24574","article-title":"Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways","volume":"60","author":"Filer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.09.023_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0125","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.09.023_bb0130","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/j.1523-1755.2000.00366.x","article-title":"Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats","volume":"58","author":"Tsuchiyama","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2016.09.023_bb0135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0961203310388444","article-title":"Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB\u00d7NZW) F1 mice from lupus-like disease","volume":"20","author":"Liu","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.09.023_bb0140","doi-asserted-by":"crossref","first-page":"e60807","DOI":"10.1371\/journal.pone.0060807","article-title":"Galectin-9 ameliorates clinical severity of MRL\/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3","volume":"8","author":"Moritoki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.023_bb0145","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1681\/ASN.2004110915","article-title":"Galectin-9 inhibits glomerular hypertrophy in db\/db diabetic mice via cell-cycle-dependent mechanisms","volume":"16","author":"Baba","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0150","article-title":"Delayed ischemic preconditioning in the presence of galectin-9 protects against renal ischemic injury through a regulatory T-cell dependent mechanism","author":"Zhang","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.autrev.2016.09.023_bb0155","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1432-2277.2008.00705.x","article-title":"A role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury","volume":"21","author":"Fernandes Bertocchi","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.autrev.2016.09.023_bb0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/path.2536","article-title":"Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms","volume":"218","author":"Iacobini","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0165","doi-asserted-by":"crossref","first-page":"e18683","DOI":"10.1371\/journal.pone.0018683","article-title":"Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury","volume":"6","author":"Kolatsi-Joannou","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2016.09.023_bb0170","doi-asserted-by":"crossref","first-page":"P76","DOI":"10.1186\/2046-2530-1-S1-P76","article-title":"A central role for Galectin 3 during renal epithelial cell morphogenesis after nephrectomy","volume":"1","author":"Poirier","year":"2012","journal-title":"Cilia"},{"key":"10.1016\/j.autrev.2016.09.023_bb0175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis","volume":"172","author":"Henderson","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0180","doi-asserted-by":"crossref","first-page":"F245","DOI":"10.1152\/ajprenal.00326.2010","article-title":"Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis","volume":"300","author":"Okamura","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/TP.0b013e318242f40a","article-title":"Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3","volume":"93","author":"Dang","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2016.09.023_bb0190","doi-asserted-by":"crossref","first-page":"F500","DOI":"10.1152\/ajprenal.00461.2014","article-title":"Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy","volume":"308","author":"Frenay","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.autrev.2016.09.023_bb0200","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0002-9440(10)63486-4","article-title":"Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(\u2212\/\u2212) mice","volume":"163","author":"Ma","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0205","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","article-title":"Regulation of alternative macrophage activation by galectin-3","volume":"180","author":"MacKinnon","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.intimp.2015.01.003","article-title":"Enalapril treatment increases T cell number and promotes polarization towards M1-like macrophages locally in diabetic nephropathy","volume":"25","author":"Cucak","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0215","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1083\/jcb.200704042","article-title":"Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix","volume":"179","author":"Wipff","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0220","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.3892\/mmr.2015.4075","article-title":"Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells","volume":"12","author":"Tian","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2016.09.023_bb0225","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-08-4153","article-title":"Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity","volume":"69","author":"Song","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2016.09.023_bb0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.30116","article-title":"Alterations in Wnt pathway activity in mouse serum and kidneys during lupus development","volume":"63","author":"Tveita","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.09.023_bb0235","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1096\/fj.15-272443","article-title":"DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney","volume":"29","author":"Pushpakumar","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2016.09.023_bb0240","series-title":"ASN kidney week annual meeting","author":"Pergola","year":"2014"},{"key":"10.1016\/j.autrev.2016.09.023_bb0245","first-page":"89","article-title":"Role of galectins in re-epithelialization of wounds","volume":"2","author":"Panjwani","year":"2014","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.autrev.2016.09.023_bb0250","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2478\/v10042-009-0069-0","article-title":"Expression of galectin-3 in nephrotic syndrome glomerulopaties in children","volume":"47","author":"Ostalska-Nowicka","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2005.04.083","article-title":"Adoptive transfer of macrophages ameliorates renal fibrosis in mice","volume":"332","author":"Nishida","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2016.09.023_bb0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08977194.2013.787994","article-title":"IL-1\u03b2 suppresses TGF-\u03b2-mediated myofibroblast differentiation in cardiac fibroblasts","volume":"31","author":"Br\u00f8nnum","year":"2013","journal-title":"Growth Factors"},{"key":"10.1016\/j.autrev.2016.09.023_bb0265","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ibd.21443","article-title":"Matrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cells","volume":"17","author":"Puthenedam","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2016.09.023_bb0270","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1242\/jcs.148510","article-title":"Molecular basis for MMP9 induction and disruption of epithelial cell\u2013cell contacts by galectin-3","volume":"127","author":"Mauris","year":"2014","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2016.09.023_bb0275","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-4165(97)00086-X","article-title":"Modulation of the biological functions of galectin-3 by matrix metalloproteinases","volume":"1379","author":"Ochieng","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2016.09.023_bb0280","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0002-9440(10)64959-0","article-title":"Galectin-3 induces endothelial cell morphogenesis and angiogenesis","volume":"156","author":"Nangia-Makker","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0961203308094361","article-title":"Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis","volume":"18","author":"Kang","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.09.023_bb0290","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10875-011-9618-3","article-title":"Galectin-8 in IgA nephritis: decreased binding of IgA by galectin-8 affinity chromatography and associated increased binding in non-IgA serum glycoproteins","volume":"32","author":"Carlsson","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0295","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00441-015-2203-y","article-title":"Lack of galectin-3 up-regulates IgA expression by peritoneal B1 lymphocytes during B cell differentiation","volume":"363","author":"Oliveira","year":"2016","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.autrev.2016.09.023_bb0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cbin.10363","article-title":"High glucose-induced Galectin-1 in human podocytes implicates the involvement of Galectin-1 in diabetic nephropathy","volume":"39","author":"Liu","year":"2015","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.autrev.2016.09.023_bb0305","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2353\/ajpath.2007.060389","article-title":"Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection","volume":"170","author":"Silva-Monteiro","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0310","doi-asserted-by":"crossref","first-page":"14496","DOI":"10.1073\/pnas.0903497106","article-title":"Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.09.023_bb0315","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2012.09.003","article-title":"Emerging and critical issues in the pathogenesis of lupus","volume":"12","author":"Gatto","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/glycob\/cws120","article-title":"Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"23","author":"Sarter","year":"2013","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2016.09.023_bb0325","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009740903013213","article-title":"Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus","volume":"39","author":"Montiel","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.38891","article-title":"Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus","volume":"67","author":"Shi","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.09.023_bb0335","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/0961203308099973","article-title":"Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation","volume":"18","author":"Massardo","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.09.023_bb0340","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4067\/S0716-97602013000300008","article-title":"Galectin-8 binds to LFA-1, blocks its interaction with ICAM-1 and is counteracted by anti-Gal-8 autoantibodies isolated from lupus patients","volume":"46","author":"Vicu\u00f1a","year":"2013","journal-title":"Biol Res"},{"key":"10.1016\/j.autrev.2016.09.023_bb0345","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.autrev.2015.03.002","article-title":"Neutrophil extracellular traps and their role in development of chronic inflammation and autoimmunity","volume":"14","author":"Pinegin","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0350","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1080\/15548627.2015.1052206","article-title":"B cell autophagy mediates TLR7-dependent autoimmunity and inflammation","volume":"11","author":"Weindel","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2016.09.023_bb0355","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopha.2015.02.017","article-title":"Update on the role of autophagy in systemic lupus erythematosus: a novel therapeutic target","volume":"71","author":"Pan","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2016.09.023_bb0360","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1462-5822.2009.01415.x","article-title":"Galectin-3, a marker for vacuole lysis by invasive pathogens","volume":"12","author":"Paz","year":"2010","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0365","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2015.11.004","article-title":"Role of extracellular vesicles in autoimmune diseases","volume":"15","author":"Turpin","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0370","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.autrev.2016.03.009","article-title":"\u201cKill\u201d the messenger: targeting of cell-derived microparticles in lupus nephritis","volume":"15","author":"Nielsen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000026","article-title":"Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus","volume":"1","author":"Nielsen","year":"2014","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2016.09.023_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2015.08.009","article-title":"The critical role of toll-like receptors\u2014from microbial recognition to autoimmunity: a comprehensive review","volume":"15","author":"Jim\u00e9nez-Dalmaroni","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0385","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2009.117804","article-title":"IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus","volume":"69","author":"Bassi","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.09.023_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2016.07.002","article-title":"Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB\/NZW F1 mice","author":"Gatto","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.09.023_bb0395","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2016.02.006","article-title":"Targeting Fc\u03b3Rs to treat antibody-dependent autoimmunity","volume":"15","author":"Yu","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0400","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2015.04.004","article-title":"Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference","volume":"14","author":"Bonanni","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.02.003","article-title":"Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: a comprehensive review","volume":"69","author":"Gatto","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.09.023_bb0410","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/glycob\/cwt026","article-title":"Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model","volume":"23","author":"Clark","year":"2013","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2016.09.023_bb0415","doi-asserted-by":"crossref","first-page":"23671","DOI":"10.18632\/oncotarget.4409","article-title":"Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis","volume":"6","author":"Duckworth","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2016.09.023_bb0420","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.30211","article-title":"Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes","volume":"63","author":"Hedberg","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.09.023_bb0425","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1468-3083.2010.03941.x","article-title":"Serum galectin-3 levels in patients with Beh\u00e7et's disease: association with disease activity over a long-term follow-up","volume":"25","author":"\u00d6zden","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0430","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.09.023_bb0435","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/glycob\/cwp120","article-title":"Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells","volume":"19","author":"Oliveira","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2016.09.023_bb0440","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4049\/jimmunol.172.1.493","article-title":"Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection","volume":"172","author":"Acosta-Rodr\u00edguez","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0445","doi-asserted-by":"crossref","first-page":"e71458","DOI":"10.1371\/journal.pone.0071458","article-title":"Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease","volume":"8","author":"Villalta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.023_bb0450","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar3251","article-title":"Abnormalities of T cell signaling in systemic lupus erythematosus","volume":"13","author":"Moulton","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.09.023_bb0455","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.autrev.2016.07.007","article-title":"Revisiting the regulatory roles of the TGF-\u03b2 family of cytokines","volume":"15","author":"Fujio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0460","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.4049\/jimmunol.1202122","article-title":"Galectin-3 negatively regulates dendritic cell production of IL-23\/IL-17-axis cytokines in infection by Histoplasma capsulatum","volume":"190","author":"Wu","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0465","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ndt\/gfn565","article-title":"Cyclosporine (CsA) in lupus nephritis: assessing the evidence","volume":"24","author":"Moroni","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2016.09.023_bb0470","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2015.09.006","article-title":"Tacrolimus use in lupus nephritis: a systematic review and meta-analysis","volume":"15","author":"Annah","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0475","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","article-title":"The fibrosis marker galectin-3 and outcome in the general population","volume":"272","author":"de Boer","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2016.09.023_bb0480","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0485","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1681\/ASN.2012090909","article-title":"Elevated galectin-3 precedes the development of CKD","volume":"24","author":"O'Seaghdha","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0490","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/jcp.24318","article-title":"Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro","volume":"228","author":"Saksida","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0495","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12933-015-0230-3","article-title":"Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes","volume":"14","author":"Darrow","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057915","article-title":"Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice","volume":"8","author":"Pang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.023_bb0505","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40618-014-0222-2","article-title":"Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor?","volume":"38","author":"Yilmaz","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2016.09.023_bb0510","doi-asserted-by":"crossref","first-page":"9618092","DOI":"10.1155\/2016\/9618092","article-title":"Role of galectin-3 in obesity and impaired glucose homeostasis","volume":"2016","author":"Menini","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.autrev.2016.09.023_bb0515","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fphys.2015.00274","article-title":"RNA-seq analysis of glycosylation related gene expression in STZ-induced diabetic rat kidney inner medulla","volume":"6","author":"Qian","year":"2015","journal-title":"Front Physiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0520","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/diabetes.54.3.785","article-title":"Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3","volume":"54","author":"Stitt","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2016.09.023_bb0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2369-14-23","article-title":"Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease","volume":"14","author":"Kurose","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059616","article-title":"Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia","volume":"8","author":"Mishra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.023_bb0535","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1681\/ASN.2014010093","article-title":"Galectin-3, renal function, and clinical outcomes: results from the LURIC and 4D studies","volume":"26","author":"Drechsler","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0540","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/HYPERTENSIONAHA.115.06032","article-title":"Galectin-3 participates in cardiovascular remodeling associated with obesity","volume":"66","author":"Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.autrev.2016.09.023_bb0545","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/ijo.2016.19","article-title":"Galectin-3 inhibition prevents adipose tissue remodelling in obesity","volume":"40","author":"Mart\u00ednez-Mart\u00ednez","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.autrev.2016.09.023_bb0550","first-page":"904","article-title":"Protective effect of metformin on renal injury of C57BL\/6J mouse treated with high fat diet","volume":"69","author":"Zhang","year":"2014","journal-title":"Pharmazie"},{"key":"10.1016\/j.autrev.2016.09.023_bb0555","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2009-1619","article-title":"Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes","volume":"95","author":"Weigert","year":"2010","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2016.09.023_bb0560","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/00365513.2014.928944","article-title":"Association of small, dense low-density lipoprotein cholesterol and galectin-3 in patients with chronic kidney disease","volume":"74","author":"Savic","year":"2014","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.autrev.2016.09.023_bb0565","doi-asserted-by":"crossref","first-page":"A27","DOI":"10.1161\/atvb.32.suppl_1.A27","article-title":"Galectin-3 binding protein: a new factor promoting venous thrombosis","volume":"32","author":"Diaz","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0570","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/039463201102400409","article-title":"Galectin-3 and plasma cytokines in patients with acute myocardial infarction","volume":"24","author":"Falcone","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0585","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1523-1755.2001.059002415.x","article-title":"Transcription factor-kappa B (NF-kappa B) and renal disease","volume":"59","author":"Guijarro","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2016.09.023_bb0590","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/HJH.0b013e32831997d6","article-title":"Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension","volume":"27","author":"Hartner","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.autrev.2016.09.023_bb0595","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2016-203631","article-title":"A pilot study to demonstrate diagnostic potential of galectin-3 levels in saliva","author":"Zhang","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0600","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3909\/ricm0726","article-title":"Utilization of galectin-3 in case management across the spectrum of heart failure","volume":"15","author":"McCullough","year":"2014","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.autrev.2016.09.023_bb0605","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin","volume":"296","author":"Liu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0610","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.autrev.2016.09.023_bb0615","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1172\/JCI200215045","article-title":"Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis","volume":"110","author":"Nishida","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2016.09.023_bb0620","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.autrev.2016.09.023_bb0625","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/jim-2015-000014","article-title":"The relation among aldosterone, galectin-3, and myocardial fibrosis: a prospective clinical pilot follow-up study","volume":"64","author":"Liao","year":"2016","journal-title":"J Invest Med"},{"key":"10.1016\/j.autrev.2016.09.023_bb0630","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1159\/000355736","article-title":"Eplerenone-mediated aldosterone blockade prevents renal fibrosis by reducing renal inflammation, interstitial cell proliferation and oxidative stress","volume":"37","author":"Chen","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.autrev.2016.09.023_bb0635","doi-asserted-by":"crossref","first-page":"e81090","DOI":"10.1371\/journal.pone.0081090","article-title":"Spironolactone attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in circulating and alveolar compartments","volume":"8","author":"Ji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.09.023_bb0640","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.autrev.2016.09.023_bb0645","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchf.2014.07.015","article-title":"Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33\/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction","volume":"3","author":"Lax","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.autrev.2016.09.023_bb0650","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ahj.2014.12.012","article-title":"Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction","volume":"169","author":"Gandhi","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2016.09.023_bb0655","series-title":"Dansk Endokrinologisk Selskab \u00c5rsm\u00f8de","article-title":"Effect of aldosterone receptor blockade on galectin 3 in patients with diabetic nephropathy. Diabetes complications (41)","author":"Lindhardt","year":"2014"},{"key":"10.1016\/j.autrev.2016.09.023_bb0660","first-page":"1","article-title":"Galectin-3 and prediction of therapeutic response to renal sympathetic denervation","volume":"9","author":"Schwerg","year":"2016","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.autrev.2016.09.023_bb0665","first-page":"345","article-title":"Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling","volume":"20","author":"Zhang","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2016.09.023_bb0670","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clinbiochem.2014.06.019","article-title":"Alternations of galectin levels after renal transplantation","volume":"47","author":"Tan","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2016.09.023_bb0675","doi-asserted-by":"crossref","DOI":"10.1177\/0003319715623397","article-title":"Predictive value for galectin 3 and Cardiotrophin 1 in hemodialysis patients","author":"Hogas","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.autrev.2016.09.023_bb0680","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1157\/13084636","article-title":"Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile","volume":"59","author":"Grigorian Shamagian","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0685","doi-asserted-by":"crossref","first-page":"e000760","DOI":"10.1161\/JAHA.112.000760","article-title":"Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure","volume":"1","author":"Gopal","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.autrev.2016.09.023_bb0690","doi-asserted-by":"crossref","first-page":"e28952","DOI":"10.5812\/cardiovascmed.28952","article-title":"Galectin-3 serum levels are independently associated with microalbuminuria in chronic heart failure outpatients","volume":"5","author":"Iacoviello","year":"2015","journal-title":"Res Cardiovasc Med"},{"key":"10.1016\/j.autrev.2016.09.023_bb0695","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6890-14-15","article-title":"Galectin-1 and galectin-3 mRNA expression in renal cell carcinoma","volume":"14","author":"von Klot","year":"2014","journal-title":"BMC Clin Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0700","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.anndiagpath.2012.07.002","article-title":"Role of carbonic anhydrase IX, \u03b1-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study","volume":"17","author":"Bing","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0705","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1442-2042.2012.03206.x","article-title":"Potential tumor markers of renal cell carcinoma: \u03b1-enolase for postoperative follow up, and galectin-1 and galectin-3 for primary detection","volume":"20","author":"Kaneko","year":"2013","journal-title":"Int J Urol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0710","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4161\/cbt.25937","article-title":"Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment","volume":"14","author":"Xu","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.autrev.2016.09.023_bb0715","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1756-9966-30-89","article-title":"Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma","volume":"30","author":"Straube","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.autrev.2016.09.023_bb0720","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/1535370216630839","article-title":"Antitumor effects of galectin-3 inhibition in human renal carcinoma cells","volume":"241","author":"Xu","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.autrev.2016.09.023_bb0725","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1007\/s13277-015-3248-y","article-title":"Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma","volume":"36","author":"Fu","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.autrev.2016.09.023_bb0730","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3892\/br.2014.334","article-title":"Induction of HLA-A*33-restricted cytotoxic lymphocytes against renal cell carcinoma targeting galectin 9 and PINCH","volume":"2","author":"Kawashima","year":"2014","journal-title":"Biomed Rep"},{"issue":"4 Suppl 99","key":"10.1016\/j.autrev.2016.09.023_bb9000","first-page":"S48","article-title":"Role of galectin-3 in prevention and treatment of lupus glomerulonephritis in NZB\/NZW F1 mice","volume":"34","author":"Saccon","year":"2016","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630218X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630218X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T23:09:06Z","timestamp":1657321746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721630218X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":145,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S156899721630218X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.023","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of galectin-3 in autoimmune and non-autoimmune nephropathies","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}